Global and United States Natural Source Antitumor Medicine In-Depth Research Report 2017-2022

Published: Aug, 2017 | Pages: 127 | Publisher: US Market Insight (UMI)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Natural Source Antitumor Medicine industry.

Major Companies
    ABRAXIS BIOSCIENCE
    ACTAVIS TOTOWA
    AKORN
    APOTEX INC
    BRISTOL MYERS SQUIBB
    CIPLA LTD
    DR REDDYS LABS LTD
    FRESENIUS KABI USA
    GLAND PHARMA LTD
    HIKMA INTL PHARMS
    HOSPIRA
    HQ SPCLT PHARMA
    INGENUS PHARMS NJ
    IPSEN INC
    MERCK
    MYLAN
    NOVARTIS PHARMS CORP
    PFIZER INC
    SANDOZ
    SANOFI AVENTIS US
    SUN PHARMA GLOBAL
    TEVA PHARMS
    WATSON LABS
    WEST-WARD PHARMS INT

Key Regions
    North America
        United States
            California
            Texas
            New York
            Others
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main types of products
Natural Source Antitumor Medicine Market, by Natural Source
    Topotecan
    Camptothecin
    Rubitecan
    Paclitaxel
    Colchicine
    Etoposide
    Docetaxel
    Resveratrol
    Podophyllotoxin
    Irinotecan
    Cantharidin
    Harringtonolide
    Vinblastine
    Epothilone

Natural Source Antitumor Medicine Market, by Key Consumers
    Department of Oncology
    Department of Chemotherapy
    Pharmacology

 Table of Contents

Global and United States Natural Source Antitumor Medicine In-Depth Research Report 2017-2022
Chapter One Global Natural Source Antitumor Medicine Market Overview
    1.1 Global Natural Source Antitumor Medicine Market Sales Volume Revenue and Price 2012-2017
    1.2 Natural Source Antitumor Medicine, by Natural Source 2012-2017
        1.2.1 Global Natural Source Antitumor Medicine Sales Market Share by Natural Source 2012-2017
        1.2.2 Global Natural Source Antitumor Medicine Revenue Market Share by Natural Source 2012-2017
        1.2.3 Global Natural Source Antitumor Medicine Price by Natural Source 2012-2017
        1.2.4 Topotecan
        1.2.5 Camptothecin
        1.2.6 Rubitecan
        1.2.7 Paclitaxel
        1.2.8 Colchicine
              Etoposide
              Docetaxel
              Resveratrol
              Podophyllotoxin
              Irinotecan
              Cantharidin
              Harringtonolide
              Vinblastine
              Epothilone

Chapter Two United States Natural Source Antitumor Medicine Market Overview
    2.1 United States Natural Source Antitumor Medicine Market Sales Volume Revenue and Price 2012-2017
    2.2 Natural Source Antitumor Medicine, by Natural Source 2012-2017
        2.2.1 United States Natural Source Antitumor Medicine Sales Market Share by Natural Source 2012-2017
        2.2.2 United States Natural Source Antitumor Medicine Revenue Market Share by Natural Source 2012-2017
        2.2.3 United States Natural Source Antitumor Medicine Price by Natural Source 2012-2017
        2.2.4 Topotecan
        2.2.5 Camptothecin
        2.2.6 Rubitecan
        2.2.7 Paclitaxel
        2.2.8 Colchicine
              Etoposide
              Docetaxel
              Resveratrol
              Podophyllotoxin
              Irinotecan
              Cantharidin
              Harringtonolide
              Vinblastine
              Epothilone

Chapter Three Natural Source Antitumor Medicine by Regions 2012-2017
    3.1 Global Natural Source Antitumor Medicine Sales Market Share by Regions 2012-2017
    3.2 Global Natural Source Antitumor Medicine Revenue Market Share by Regions 2012-2017
    3.3 Global Natural Source Antitumor Medicine Price by Regions 2012-2017
    3.4 North America
        3.4.1 United States
            3.4.1.1 California
            3.4.1.2 Texas
            3.4.1.3 New York
            3.4.1.4 Others in United States
        3.4.2 Canada
    3.5 Latin America
        3.5.1 Mexico
        3.5.2 Brazil
        3.5.3 Argentina
        3.5.4 Others in Latin America
    3.6 Europe
        3.6.1 Germany
        3.6.2 United Kingdom
        3.6.3 France
        3.6.4 Italy
        3.6.5 Spain
        3.6.6 Russia
        3.6.7 Netherland
        3.6.8 Others in Europe
    3.7 Asia & Pacific
        3.7.1 China
        3.7.2 Japan
        3.7.3 India
        3.7.4 Korea
        3.7.5 Australia
        3.7.6 Southeast Asia
            3.7.6.1 Indonesia
            3.7.6.2 Thailand
            3.7.6.3 Philippines
            3.7.6.4 Vietnam
            3.7.6.5 Singapore
            3.7.6.6 Malaysia
            3.7.6.7 Others in Southeast Asia
    3.8 Africa & Middle East
        3.8.1 South Africa
        3.8.2 Egypt
        3.8.3 Turkey
        3.8.4 Saudi Arabia
        3.8.5 Iran
        3.8.6 Others in Africa & Middle East

Chapter Four Global Natural Source Antitumor Medicine by Companies 2012-2017
    4.1 Global Natural Source Antitumor Medicine Sales Volume Market Share by Companies 2012-2017
    4.2 Global Natural Source Antitumor Medicine Revenue Share by Companies 2012-2017
    4.3 Global Top Companies Natural Source Antitumor Medicine Key Product Model and Market Performance
    4.4 Global Top Companies Natural Source Antitumor Medicine Key Target Consumers and Market Performance

Chapter Five United States Natural Source Antitumor Medicine by Companies 2012-2017
    5.1 United States Natural Source Antitumor Medicine Sales Volume Market Share by Companies 2012-2017
    5.2 United States Natural Source Antitumor Medicine Revenue Share by Companies 2012-2017
    5.3 United States Top Companies Natural Source Antitumor Medicine Key Product Model and Market Performance
    5.4 United States Top Companies Natural Source Antitumor Medicine Key Target Consumers and Market Performance

Chapter Six Global Natural Source Antitumor Medicine by Consumer 2012-2017
    6.1 Global Natural Source Antitumor Medicine Sales Market Share by Consumer 2012-2017
    6.2 Department of Oncology
    6.3 Department of Chemotherapy
    6.4 Pharmacology
    6.5 Consuming Habit and Preference

Chapter Seven Global Natural Source Antitumor Medicine by Consumer 2012-2017
    7.1 Global Natural Source Antitumor Medicine Sales Market Share by Consumer 2012-2017
    7.2 Department of Oncology
    7.3 Department of Chemotherapy
    7.4 Pharmacology
    7.5 Consuming Habit and Preference

Chapter Eight Top Companies Profile
    8.1 ABRAXIS BIOSCIENCE
        8.1.1 ABRAXIS BIOSCIENCE Company Details and Competitors
        8.1.2 ABRAXIS BIOSCIENCE Key Natural Source Antitumor Medicine Models and Performance
        8.1.3 ABRAXIS BIOSCIENCE Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
        8.1.4 ABRAXIS BIOSCIENCE Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
    8.2 ACTAVIS TOTOWA
        8.2.1 ACTAVIS TOTOWA Company Details and Competitors
        8.2.2 ACTAVIS TOTOWA Key Natural Source Antitumor Medicine Models and Performance
        8.2.3 ACTAVIS TOTOWA Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
        8.2.4 ACTAVIS TOTOWA Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
    8.3 AKORN
        8.3.1 AKORN Company Details and Competitors
        8.3.2 AKORN Key Natural Source Antitumor Medicine Models and Performance
        8.3.3 AKORN Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
        8.3.4 AKORN Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
    8.4 APOTEX INC
        8.4.1 APOTEX INC Company Details and Competitors
        8.4.2 APOTEX INC Key Natural Source Antitumor Medicine Models and Performance
        8.4.3 APOTEX INC Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
        8.4.4 APOTEX INC Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
    8.5 BRISTOL MYERS SQUIBB
        8.5.1 BRISTOL MYERS SQUIBB Company Details and Competitors
        8.5.2 BRISTOL MYERS SQUIBB Key Natural Source Antitumor Medicine Models and Performance
        8.5.3 BRISTOL MYERS SQUIBB Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
        8.5.4 BRISTOL MYERS SQUIBB Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
    8.6 CIPLA LTD
        8.6.1 CIPLA LTD Company Details and Competitors
        8.6.2 CIPLA LTD Key Natural Source Antitumor Medicine Models and Performance
        8.6.3 CIPLA LTD Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
        8.6.4 CIPLA LTD Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
    8.7 DR REDDYS LABS LTD
        8.7.1 DR REDDYS LABS LTD Company Details and Competitors
        8.7.2 DR REDDYS LABS LTD Key Natural Source Antitumor Medicine Models and Performance
        8.7.3 DR REDDYS LABS LTD Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
        8.7.4 DR REDDYS LABS LTD Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
    8.8 FRESENIUS KABI USA
        8.8.1 FRESENIUS KABI USA Company Details and Competitors
        8.8.2 FRESENIUS KABI USA Key Natural Source Antitumor Medicine Models and Performance
        8.8.3 FRESENIUS KABI USA Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
        8.8.4 FRESENIUS KABI USA Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
    8.9 GLAND PHARMA LTD
        8.9.1 GLAND PHARMA LTD Company Details and Competitors
        8.9.2 GLAND PHARMA LTD Key Natural Source Antitumor Medicine Models and Performance
        8.9.3 GLAND PHARMA LTD Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
        8.9.4 GLAND PHARMA LTD Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
    8.10 HIKMA INTL PHARMS
        8.10.1 HIKMA INTL PHARMS Company Details and Competitors
        8.10.2 HIKMA INTL PHARMS Key Natural Source Antitumor Medicine Models and Performance
        8.10.3 HIKMA INTL PHARMS Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
        8.10.4 HIKMA INTL PHARMS Natural Source Antitumor Medicine Sales Volume Revenue Price Cost and Gross Margin
    8.11 HOSPIRA
    8.12 HQ SPCLT PHARMA
    8.13 INGENUS PHARMS NJ
    8.14 IPSEN INC
    8.15 MERCK
    8.16 MYLAN
    8.17 NOVARTIS PHARMS CORP
    8.18 PFIZER INC
    8.19 SANDOZ
    8.20 SANOFI AVENTIS US
    8.21 SUN PHARMA GLOBAL
    8.22 TEVA PHARMS
    8.23 WATSON LABS
    8.24 WEST-WARD PHARMS INT

Chapter Nine Industry Chain and Supply Chain
    9.1 Natural Source Antitumor Medicine Industry Chain Structure
        9.1.1 R&D
        9.1.2 Raw Materials (Components)
        9.1.3 Manufacturing Plants
        9.1.4 Regional Trading (Import Export and Local Sales)
        9.1.5 Online Sales Channel
        9.1.6 Offline Channel
        9.1.7 End Users
    9.2 Natural Source Antitumor Medicine Manufacturing
        9.2.1 Key Components
        9.2.2 Assembly Manufacturing
    9.3 Consumer Preference
    9.4 Behavioral Habits
    9.5 Marketing Environment

Chapter Ten Global Natural Source Antitumor Medicine Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Natural Source Antitumor Medicine Sales (), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Natural Source Antitumor Medicine Sales () Forecast by Regions (2017-2022)
    10.3 Global Natural Source Antitumor Medicine Sales () Forecast by Application (2017-2022)
    10.4 Global Natural Source Antitumor Medicine Sales () Forecast by Natural Source (2017-2022)
    10.5 Global Natural Source Antitumor Medicine Sales () Forecast by  (2017-2022)

Chapter Eleven United States Natural Source Antitumor Medicine Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 United States Natural Source Antitumor Medicine Sales (), Revenue (Million USD) Forecast (2017-2022)
    11.2 United States Natural Source Antitumor Medicine Sales () Forecast by Regions (2017-2022)
    11.3 United States Natural Source Antitumor Medicine Sales () Forecast by Application (2017-2022)
    11.4 United States Natural Source Antitumor Medicine Sales () Forecast by Natural Source (2017-2022)
    11.5 United States Natural Source Antitumor Medicine Sales () Forecast by  (2017-2022)

Chapter Twelve Development Trend and Research Conclusion
    12.1 Development Trend
    12.2 Research Conclusion

Chapter Thirteen Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Table Global Natural Source Antitumor Medicine Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
    Figure Global Natural Source Antitumor Medicine Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Natural Source Antitumor Medicine Sales Volume () and Growth Rate (2012-2017)
    Table Global Natural Source Antitumor Medicine Sales () by Natural Source (2012-2017)
    Table Global Natural Source Antitumor Medicine Sales Market Share by Natural Source (2012-2017)
    Figure Global Natural Source Antitumor Medicine Sales Market Share by Natural Source in 2016
    Table Global Natural Source Antitumor Medicine Revenue (Million USD) by Natural Source (2012-2017)
    Table Global Natural Source Antitumor Medicine Revenue Market Share by Natural Source (2012-2017)
    Figure Global Natural Source Antitumor Medicine Revenue Market Share by Natural Source in 2016
    Table Global Natural Source Antitumor Medicine Price () by Natural Source (2012-2017)
    Table Top Companies of Topotecan Natural Source Antitumor Medicine Products List
    Figure Global Topotecan Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table Top Companies of Camptothecin Natural Source Antitumor Medicine Products List
    Figure Global Camptothecin Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table Top Companies of Rubitecan Natural Source Antitumor Medicine Products List
    Figure Global Rubitecan Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table Top Companies of Paclitaxel Natural Source Antitumor Medicine Products List
    Figure Global Paclitaxel Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table Top Companies of Colchicine Natural Source Antitumor Medicine Products List
    Figure Global Colchicine Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table Global Natural Source Antitumor Medicine Sales () by  (2012-2017)
    Table Global Natural Source Antitumor Medicine Sales Market Share by  (2012-2017)
    Figure Global Natural Source Antitumor Medicine Sales Market Share by  in 2016
    Table Global Natural Source Antitumor Medicine Revenue (Million USD) by  (2012-2017)
    Table Global Natural Source Antitumor Medicine Revenue Market Share by  (2012-2017)
    Figure Global Natural Source Antitumor Medicine Revenue Market Share by  in 2016
    Table Global Natural Source Antitumor Medicine Price () by  (2012-2017)
    Figure United States Natural Source Antitumor Medicine Revenue (Million USD) and Growth Rate (2012-2017)
    Figure United States Natural Source Antitumor Medicine Sales Volume () and Growth Rate (2012-2017)
    Table United States Natural Source Antitumor Medicine Sales () by Natural Source (2012-2017)
    Table United States Natural Source Antitumor Medicine Sales Market Share by Natural Source (2012-2017)
    Figure United States Natural Source Antitumor Medicine Sales Market Share by Natural Source in 2016
    Table United States Natural Source Antitumor Medicine Revenue (Million USD) by Natural Source (2012-2017)
    Table United States Natural Source Antitumor Medicine Revenue Market Share by Natural Source (2012-2017)
    Figure United States Natural Source Antitumor Medicine Revenue Market Share by Natural Source in 2016
    Table United States Natural Source Antitumor Medicine Price () by Natural Source (2012-2017)
    Table Top Companies of Topotecan Natural Source Antitumor Medicine Products List
    Figure United States Topotecan Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table Top Companies of Camptothecin Natural Source Antitumor Medicine Products List
    Figure United States Camptothecin Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table Top Companies of Rubitecan Natural Source Antitumor Medicine Products List
    Figure United States Rubitecan Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table Top Companies of Paclitaxel Natural Source Antitumor Medicine Products List
    Figure United States Paclitaxel Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table Top Companies of Colchicine Natural Source Antitumor Medicine Products List
    Figure United States Colchicine Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table United States Natural Source Antitumor Medicine Sales () by  (2012-2017)
    Table United States Natural Source Antitumor Medicine Sales Market Share by  (2012-2017)
    Figure United States Natural Source Antitumor Medicine Sales Market Share by  in 2016
    Table United States Natural Source Antitumor Medicine Revenue (Million USD) by  (2012-2017)
    Table United States Natural Source Antitumor Medicine Revenue Market Share by  (2012-2017)
    Figure United States Natural Source Antitumor Medicine Revenue Market Share by  in 2016
    Table United States Natural Source Antitumor Medicine Price () by  (2012-2017)
    Table Global Natural Source Antitumor Medicine Sales () by Regions (2012-2017)
    Table Global Natural Source Antitumor Medicine Sales Share by Regions (2012-2017)
    Figure Global Natural Source Antitumor Medicine Sales Market Share by Regions in 2016
    Figure Global Natural Source Antitumor Medicine Sales Market Share by Regions in 2017
    Table Global Natural Source Antitumor Medicine Revenue (Million USD) and Market Share by Regions (2012-2017)
    Table Global Natural Source Antitumor Medicine Revenue Market Share by Regions (2012-2017)
    Figure Global Natural Source Antitumor Medicine Revenue Market Share by Regions in 2016
    Figure Global Natural Source Antitumor Medicine Revenue Market Share by Regions in 2017
    Table Global Natural Source Antitumor Medicine Price () by Regions (2012-2017)
    Table North America Natural Source Antitumor Medicine Sales () by Regions (2012-2017)
    Table North America Natural Source Antitumor Medicine Revenue (Million USD) by Regions (2012-2017)
    Figure North America Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table United States Natural Source Antitumor Medicine Sales () by Regions (2012-2017)
    Table United States Natural Source Antitumor Medicine Revenue (Million USD) by Regions (2012-2017)
    Figure United States Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table Latin America Natural Source Antitumor Medicine Sales () by Regions (2012-2017)
    Table Latin America Natural Source Antitumor Medicine Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table Europe Natural Source Antitumor Medicine Sales () by Regions (2012-2017)
    Table Europe Natural Source Antitumor Medicine Revenue (Million USD) by Regions (2012-2017)
    Figure Europe Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table Asia & Pacific Natural Source Antitumor Medicine Sales () by Regions (2012-2017)
    Table Asia & Pacific Natural Source Antitumor Medicine Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table Africa & Middle East Natural Source Antitumor Medicine Sales () by Regions (2012-2017)
    Table Africa & Middle East Natural Source Antitumor Medicine Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table Global Natural Source Antitumor Medicine Sales Volume () by Major Companies (2012-2017)
    Table Global Natural Source Antitumor Medicine Sales Volume Market Share by Major Companies (2012-2017)
    Figure Global Natural Source Antitumor Medicine Sales Volume Market Share by Major Companies 2016
    Figure Global Natural Source Antitumor Medicine Sales Volume Market Share by Major Companies 2017
    Table Global Natural Source Antitumor Medicine Revenue (Million USD) by Major Companies (2012-2017)
    Table Global Natural Source Antitumor Medicine Revenue Market Share by Major Companies (2012-2017)
    Figure Global Natural Source Antitumor Medicine Revenue Market Share by Major Companies 2016
    Figure Global Natural Source Antitumor Medicine Revenue Market Share by Major Companies 2017
    Table Global Top Companies Key Product Model and Market Performance
    Table Global Top Companies Key Target Consumers and Market Performance
    Table United States Natural Source Antitumor Medicine Sales Volume () by Top Companies (2012-2017)
    Table United States Natural Source Antitumor Medicine Sales Volume Market Share by Top Companies (2012-2017)
    Figure United States Natural Source Antitumor Medicine Sales Volume Market Share by Top Companies 2016
    Figure United States Natural Source Antitumor Medicine Sales Volume Market Share by Top Companies 2017
    Table United States Natural Source Antitumor Medicine Revenue (Million USD) by Top Companies (2012-2017)
    Table United States Natural Source Antitumor Medicine Revenue Market Share by Top Companies (2012-2017)
    Figure United States Natural Source Antitumor Medicine Revenue Market Share by Top Companies 2016
    Figure United States Natural Source Antitumor Medicine Revenue Market Share by Top Companies 2017
    Table United States Top Companies Key Product Model and Market Performance
    Table United States Top Companies Key Target Consumers and Market Performance
    Table Global Natural Source Antitumor Medicine Sales () by Consumer (2012-2017)
    Figure Global Natural Source Antitumor Medicine Sales Market Share by Consumer (2012-2017)
    Figure Global Natural Source Antitumor Medicine Sales Market Share by Consumer in 2016
    Figure Global Department of Oncology Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Figure Global Department of Chemotherapy Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Figure Global Pharmacology Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table United States Natural Source Antitumor Medicine Sales () by Consumer (2012-2017)
    Figure United States Natural Source Antitumor Medicine Sales Market Share by Consumer (2012-2017)
    Figure United States Natural Source Antitumor Medicine Sales Market Share by Consumer in 2016
    Figure United States Department of Oncology Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Figure United States Department of Chemotherapy Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Figure United States Pharmacology Natural Source Antitumor Medicine Sales () and Growth Rate (2012-2017)
    Table ABRAXIS BIOSCIENCE Company Details and Competitors
    Table ABRAXIS BIOSCIENCE Key Natural Source Antitumor Medicine Models and Performance
    Table ABRAXIS BIOSCIENCE Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
    Table ABRAXIS BIOSCIENCE Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure ABRAXIS BIOSCIENCE Natural Source Antitumor Medicine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure ABRAXIS BIOSCIENCE Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
    Figure ABRAXIS BIOSCIENCE Natural Source Antitumor Medicine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure ABRAXIS BIOSCIENCE Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
    Table ACTAVIS TOTOWA Company Details and Competitors
    Table ACTAVIS TOTOWA Key Natural Source Antitumor Medicine Models and Performance
    Table ACTAVIS TOTOWA Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
    Table ACTAVIS TOTOWA Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure ACTAVIS TOTOWA Natural Source Antitumor Medicine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure ACTAVIS TOTOWA Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
    Figure ACTAVIS TOTOWA Natural Source Antitumor Medicine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure ACTAVIS TOTOWA Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
    Table AKORN Company Details and Competitors
    Table AKORN Key Natural Source Antitumor Medicine Models and Performance
    Table AKORN Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
    Table AKORN Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure AKORN Natural Source Antitumor Medicine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure AKORN Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
    Figure AKORN Natural Source Antitumor Medicine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure AKORN Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
    Table APOTEX INC Company Details and Competitors
    Table APOTEX INC Key Natural Source Antitumor Medicine Models and Performance
    Table APOTEX INC Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
    Table APOTEX INC Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure APOTEX INC Natural Source Antitumor Medicine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure APOTEX INC Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
    Figure APOTEX INC Natural Source Antitumor Medicine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure APOTEX INC Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
    Table BRISTOL MYERS SQUIBB Company Details and Competitors
    Table BRISTOL MYERS SQUIBB Key Natural Source Antitumor Medicine Models and Performance
    Table BRISTOL MYERS SQUIBB Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
    Table BRISTOL MYERS SQUIBB Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure BRISTOL MYERS SQUIBB Natural Source Antitumor Medicine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure BRISTOL MYERS SQUIBB Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
    Figure BRISTOL MYERS SQUIBB Natural Source Antitumor Medicine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure BRISTOL MYERS SQUIBB Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
    Table CIPLA LTD Company Details and Competitors
    Table CIPLA LTD Key Natural Source Antitumor Medicine Models and Performance
    Table CIPLA LTD Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
    Table CIPLA LTD Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure CIPLA LTD Natural Source Antitumor Medicine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure CIPLA LTD Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
    Figure CIPLA LTD Natural Source Antitumor Medicine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure CIPLA LTD Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
    Table DR REDDYS LABS LTD Company Details and Competitors
    Table DR REDDYS LABS LTD Key Natural Source Antitumor Medicine Models and Performance
    Table DR REDDYS LABS LTD Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
    Table DR REDDYS LABS LTD Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure DR REDDYS LABS LTD Natural Source Antitumor Medicine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure DR REDDYS LABS LTD Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
    Figure DR REDDYS LABS LTD Natural Source Antitumor Medicine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure DR REDDYS LABS LTD Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
    Table FRESENIUS KABI USA Company Details and Competitors
    Table FRESENIUS KABI USA Key Natural Source Antitumor Medicine Models and Performance
    Table FRESENIUS KABI USA Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
    Table FRESENIUS KABI USA Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure FRESENIUS KABI USA Natural Source Antitumor Medicine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure FRESENIUS KABI USA Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
    Figure FRESENIUS KABI USA Natural Source Antitumor Medicine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure FRESENIUS KABI USA Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
    Table GLAND PHARMA LTD Company Details and Competitors
    Table GLAND PHARMA LTD Key Natural Source Antitumor Medicine Models and Performance
    Table GLAND PHARMA LTD Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
    Table GLAND PHARMA LTD Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure GLAND PHARMA LTD Natural Source Antitumor Medicine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure GLAND PHARMA LTD Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
    Figure GLAND PHARMA LTD Natural Source Antitumor Medicine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure GLAND PHARMA LTD Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
    Table HIKMA INTL PHARMS Company Details and Competitors
    Table HIKMA INTL PHARMS Key Natural Source Antitumor Medicine Models and Performance
    Table HIKMA INTL PHARMS Natural Source Antitumor Medicine Business SWOT Analysis and Forecast
    Table HIKMA INTL PHARMS Natural Source Antitumor Medicine Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure HIKMA INTL PHARMS Natural Source Antitumor Medicine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure HIKMA INTL PHARMS Natural Source Antitumor Medicine Sales Market Share (%) in Global (2012-2017)
    Figure HIKMA INTL PHARMS Natural Source Antitumor Medicine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure HIKMA INTL PHARMS Natural Source Antitumor Medicine Revenue Market Share (%) in Global (2012-2017)
    Table HOSPIRA Company Details and Competitors
    Table HQ SPCLT PHARMA Company Details and Competitors
    Table INGENUS PHARMS NJ Company Details and Competitors
    Table IPSEN INC Company Details and Competitors
    Table MERCK Company Details and Competitors
    Table MYLAN Company Details and Competitors
    Table NOVARTIS PHARMS CORP Company Details and Competitors
    Table PFIZER INC Company Details and Competitors
    Table SANDOZ Company Details and Competitors
    Table SANOFI AVENTIS US Company Details and Competitors
    Table SUN PHARMA GLOBAL Company Details and Competitors
    Table TEVA PHARMS Company Details and Competitors
    Table WATSON LABS Company Details and Competitors
    Table WEST-WARD PHARMS INT Company Details and Competitors
    Figure Global Natural Source Antitumor Medicine Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure Global Natural Source Antitumor Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Natural Source Antitumor Medicine Price () Trend Forecast (2017-2022)
    Table Global Natural Source Antitumor Medicine Sales () Forecast by Regions (2017-2022)
    Table Global Natural Source Antitumor Medicine Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Natural Source Antitumor Medicine Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Natural Source Antitumor Medicine Sales Volume Share Forecast by Regions in 2022
    Table Global Natural Source Antitumor Medicine Sales () Forecast by Application (2017-2022)
    Figure Global Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Application in 2022
    Table Global Natural Source Antitumor Medicine Sales () Forecast by Natural Source (2017-2022)
    Figure Global Natural Source Antitumor Medicine Sales () Forecast by Natural Source (2017-2022)
    Figure Global Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Natural Source in 2022
    Table Global Natural Source Antitumor Medicine Sales () Forecast by  (2017-2022)
    Figure Global Natural Source Antitumor Medicine Sales () Forecast by  (2017-2022)
    Figure Global Natural Source Antitumor Medicine Sales Volume Market Share Forecast by  in 2022
    Figure United States Natural Source Antitumor Medicine Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure United States Natural Source Antitumor Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Natural Source Antitumor Medicine Price () Trend Forecast (2017-2022)
    Table United States Natural Source Antitumor Medicine Sales () Forecast by Regions (2017-2022)
    Table United States Natural Source Antitumor Medicine Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Natural Source Antitumor Medicine Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Natural Source Antitumor Medicine Sales Volume Share Forecast by Regions in 2022
    Table United States Natural Source Antitumor Medicine Sales () Forecast by Application (2017-2022)
    Figure United States Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Application (2017-2022)
    Figure United States Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Application in 2022
    Table United States Natural Source Antitumor Medicine Sales () Forecast by Natural Source (2017-2022)
    Figure United States Natural Source Antitumor Medicine Sales () Forecast by Natural Source (2017-2022)
    Figure United States Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Natural Source in 2022
    Table United States Natural Source Antitumor Medicine Sales () Forecast by  (2017-2022)
    Figure United States Natural Source Antitumor Medicine Sales () Forecast by  (2017-2022)
    Figure United States Natural Source Antitumor Medicine Sales Volume Market Share Forecast by  in 2022